Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide vs Radiotherapy for Brain Metastases Prevention in SCLC
NCT02605811Phase 2Unknown
- Sponsor
- Guangzhou Medical University
- Start
- Sep 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in small cell lung cancer (SCLC), sponsored by Guangzhou Medical University. Status: unknown.
02
Drugs
temozolomide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02605811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605811.